These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24378204)

  • 1. Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia.
    Kim YS; Kim DW; Jung KH; Lee ST; Kang BS; Byun JI; Yeom JS; Chu K; Lee SK
    Seizure; 2014 Mar; 23(3):208-12. PubMed ID: 24378204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy.
    Lin CH; Lu CH; Wang FJ; Tsai MH; Chang WN; Tsai NW; Lai SL; Tseng YL; Chuang YC
    Clin Neuropharmacol; 2010; 33(6):293-6. PubMed ID: 20881597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
    Berghuis B; van der Palen J; de Haan GJ; Lindhout D; Koeleman BPC; Sander JW;
    Epilepsia; 2017 Jul; 58(7):1227-1233. PubMed ID: 28542738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyponatremia from oxcarbazepine and carbamazepine.
    Dong X; Leppik IE; White J; Rarick J
    Neurology; 2005 Dec; 65(12):1976-8. PubMed ID: 16380624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
    Berghuis B; Hulst J; Sonsma A; McCormack M; de Haan GJ; Sander JW; Lindhout D; Koeleman BPC
    Epilepsia; 2021 Mar; 62(3):778-784. PubMed ID: 33576502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy.
    Ortenzi A; Paggi A; Foschi N; Sabbatini D; Pistoli E
    Funct Neurol; 2008; 23(2):97-100. PubMed ID: 18671911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine and Hyponatremia.
    Čiauškaitė J; Gelžinienė G; Jurkevičienė G
    Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35629976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic drugs-induced hyponatremia: Review and analysis of 560 hospitalized patients.
    Intravooth T; Staack AM; Juerges K; Stockinger J; Steinhoff BJ
    Epilepsy Res; 2018 Jul; 143():7-10. PubMed ID: 29631131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy.
    Dogan EA; Usta BE; Bilgen R; Senol Y; Aktekin B
    Epilepsy Behav; 2008 Jul; 13(1):156-61. PubMed ID: 18331816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyponatremic coma under oxcarbazepine therapy.
    Steinhoff BJ; Stoll KD; Stodieck SR; Paulus W
    Epilepsy Res; 1992 Mar; 11(1):67-70. PubMed ID: 1563340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia.
    Berghuis B; de Haan GJ; van den Broek MP; Sander JW; Lindhout D; Koeleman BP
    Eur J Neurol; 2016 Sep; 23(9):1393-9. PubMed ID: 27333872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of oxcarbazepine for treatment of refractory status epilepticus.
    Kellinghaus C; Berning S; Stögbauer F
    Seizure; 2014 Feb; 23(2):151-4. PubMed ID: 24295895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxcarbazepine on sodium concentration and water handling.
    Sachdeo RC; Wasserstein A; Mesenbrink PJ; D'Souza J
    Ann Neurol; 2002 May; 51(5):613-20. PubMed ID: 12112108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for hyponatremia in adult epilepsy patients: Large-scale cross-sectional cohort study.
    Yamamoto Y; Takahashi Y; Imai K; Ohta A; Kagawa Y; Inoue Y
    Seizure; 2019 Dec; 73():26-30. PubMed ID: 31707295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
    Sattler A; Schaefer M; May TW
    Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatremia induced by antiepileptic drugs in patients with epilepsy.
    Lu X; Wang X
    Expert Opin Drug Saf; 2017 Jan; 16(1):77-87. PubMed ID: 27737595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
    Kim DW; Lee SY; Shon YM; Kim JH
    Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of severe hyponatremia in a patient suffering from epilepsy and using oxcarbazepine].
    Gumbrevicius G; Sveikata A
    Medicina (Kaunas); 2006; 42(8):649-52. PubMed ID: 16963831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.